Government to make decision on Cystic Fibrosis medicine Orkambi

HSE management is to consider a proposal from the drug’s manufacturer, Vertex Pharmaceuticals

5th February, 2017

Ministers are to decide on the affordability of cystic fibrosis drug Orkambi this month.

HSE management is to consider a proposal from the drug’s manufacturer, Vertex Pharmaceuticals, in coming weeks after a previous offer was deemed too expensive to fund.

The company had demanded €159,000 per patient, per year, which would cost the HSE €391 million over five years.

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Does Britain give us cause for hope?

Health Rachel Lavin 17 hours ago

HSE chief: Ireland in ‘final countdown’ stage of vaccinations

Health Daniel Murray 17 hours ago

Lucinda Creighton: We should harness Olympic glory to tackle our weight crisis

Health Lucinda Creighton 17 hours ago

Thérapie to offer egg freezing service to women in their 20s

Health Rosanna Cooney 17 hours ago